Shlipak MG - Search Results

1

Association of tenofovir exposure with kidney disease risk in HIV infection.

Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, Shlipak MG. Scherzer R, et al. Among authors: shlipak mg. AIDS. 2012 Apr 24;26(7):867-75. doi: 10.1097/QAD.0b013e328351f68f. AIDS. 2012. PMID: 22313955 Free PMC article.

2

Cardiovascular disease risk status in elderly persons with renal insufficiency.

Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Shlipak MG, et al. Kidney Int. 2002 Sep;62(3):997-1004. doi: 10.1046/j.1523-1755.2002.00522.x. Kidney Int. 2002. PMID: 12164883 Free article.

3

Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study.

Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Ix JH, et al. Among authors: shlipak mg. J Am Soc Nephrol. 2003 Dec;14(12):3233-8. doi: 10.1097/01.asn.0000095642.25603.7a. J Am Soc Nephrol. 2003. PMID: 14638921 Free PMC article.

4

Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD; Heart and Estrogen/Progestin Replacement Study (HERS) Investigators. Shlipak MG, et al. Am J Kidney Dis. 2004 Jan;43(1):37-44. doi: 10.1053/j.ajkd.2003.08.044. Am J Kidney Dis. 2004. PMID: 14712425

5

Physical and sexual function in women with chronic kidney disease.

Kurella M, Ireland C, Hlatky MA, Shlipak MG, Yaffe K, Hulley SB, Chertow GM. Kurella M, et al. Among authors: shlipak mg. Am J Kidney Dis. 2004 May;43(5):868-76. doi: 10.1053/j.ajkd.2003.12.050. Am J Kidney Dis. 2004. PMID: 15112178

6

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.

Hsu CY, Vittinghoff E, Lin F, Shlipak MG. Hsu CY, et al. Among authors: shlipak mg. Ann Intern Med. 2004 Jul 20;141(2):95-101. doi: 10.7326/0003-4819-141-2-200407200-00007. Ann Intern Med. 2004. PMID: 15262664

7

Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.

Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM. Shlipak MG, et al. J Am Soc Nephrol. 2004 Aug;15(8):2195-203. doi: 10.1097/01.ASN.0000135121.81744.75. J Am Soc Nephrol. 2004. PMID: 15284305 Clinical Trial.

8

Association of chronic kidney disease and anemia with physical capacity: the heart and soul study.

Odden MC, Whooley MA, Shlipak MG. Odden MC, et al. Among authors: shlipak mg. J Am Soc Nephrol. 2004 Nov;15(11):2908-15. doi: 10.1097/01.ASN.0000143743.78092.E3. J Am Soc Nephrol. 2004. PMID: 15504944 Free PMC article.

9

Are small changes in serum creatinine an important risk factor?

Praught ML, Shlipak MG. Praught ML, et al. Among authors: shlipak mg. Curr Opin Nephrol Hypertens. 2005 May;14(3):265-70. doi: 10.1097/01.mnh.0000165894.90748.72. Curr Opin Nephrol Hypertens. 2005. PMID: 15821421 Review.

10

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B. Shlipak MG, et al. JAMA. 2005 Apr 13;293(14):1737-45. doi: 10.1001/jama.293.14.1737. JAMA. 2005. PMID: 15827312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

719 results

Search Page

Filters